4Accepted Oct 20, 4:33 PM ET
Cytokinetics Inc: director Harrington Robert Arthur received 195 shares
Accepted (ET)
4:33 PM
Oct 20, 2026
Filed
Oct 20, 2026
Documents
1
Size
4.6 KB
Summary
Cytokinetics Inc: director Harrington Robert Arthur received 195 shares
What happened Harrington Robert Arthur, a director, received 195 shares (transaction code A) on Oct 16, 2026 at $63.92 per share, for $12,464, according to the Form 4 filed Oct 20, 2026.
Key details
- Transaction date and price: Oct 16, 2026; $63.92 per share; total $12,464.
- Transaction code: A (award/acquisition).
- Shares owned after the transaction: not reported in the Form 4.
- Footnote: director equity in lieu of cash retainer program (F1).
- Form 4 filing date: Oct 20, 2026.
Why it may matter
- The filing reports an award under the company's director equity in lieu of cash retainer program, which is a compensation issuance rather than a market purchase or sale.
A filing does not show why the insider traded or why the company acted.